Beta blockers and chronic heart failure patients: Prognostic impact of a dose targeted beta blocker therapy vs heart rate targeted strategy

May 18, 2018

Beta blockers and chronic heart failure patients: Prognostic impact of a dose targeted beta blocker therapy vs heart rate targeted strategy

Published on 05/17/2018

previous post: Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): An international randomised, placebo-controlled, phase 3 superiority trial
next post: <em>LAPTM4B</em> gene copy number gain is associated with inferior response to anthracycline-based chemotherapy in hormone receptor negative breast carcinomas